Development Level

Tclin 3 | 613
Tchem 2 | 1,598
Tbio 1 | 11,445

IMPC Phenotype

preweaning lethality, complete... 2 | 979
abnormal embryo size 1 | 220
abnormal gait 1 | 69
abnormal kidney morphology 1 | 65
abnormal seminal vesicle morph... 1 | 114
decreased heart weight 1 | 27
decreased vertical activity 1 | 208
embryonic lethality prior to t... 1 | 278

Disease

Atherosclerosis 5 | 291
Carcinoma 5 | 11,493
Lipid metabolism disorder 5 | 114
diabetes mellitus 5 | 1,728
invasive ductal carcinoma 5 | 2,951
osteosarcoma 5 | 7,950
Hepatomegaly 4 | 285
ductal carcinoma in situ 4 | 1,745
tuberculosis 4 | 2,010
Colorectal Neoplasms 3 | 243
Coronary artery disease 3 | 268
Kidney Failure, Chronic 3 | 46
Obesity 3 | 678
Schizophrenia 3 | 1,160
active ulcerative colitis 3 | 764
adrenocortical carcinoma 3 | 1,428
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
lung cancer 3 | 4,740
malignant mesothelioma 3 | 3,232
medulloblastoma, large-cell 3 | 6,241
ovarian cancer 3 | 8,520
psoriasis 3 | 6,694
Alzheimer's disease 2 | 658
Astrocytoma, Pilocytic 2 | 3,081
Autosomal recessive predisposition 2 | 1,442
Cancer 2 | 2,499
Carcinoma, Hepatocellular 2 | 228
Chemical and Drug Induced Liver Injury 2 | 195
Cholestasis 2 | 155
Crohn Disease 2 | 45
Diabetes Mellitus, Experimental 2 | 108
Diabetes Mellitus, Non-Insulin-Dependent 2 | 145
Diabetes Mellitus, Type 2 2 | 142
Diabetic dyslipidemia associated with type 2 diabetes mellitus 2 | 2
Down syndrome 2 | 499
Dyslipidemias 2 | 27
Fatty Liver 2 | 70
Fatty liver disease 2 | 103
Heart disease 2 | 306
High density lipoprotein decreased 2 | 10
Hypercholesterolemia 2 | 44
Hyperglycemia 2 | 137
Hyperinsulinism 2 | 133
Hyperlipidemia 2 | 43
Hypertension 2 | 396
Hypertensive disease 2 | 292
Hypertriglyceridemia result 2 | 37
Hypoalphalipoproteinemias 2 | 10
Inflammation 2 | 120
Insulin Resistance 2 | 72
Liver carcinoma 2 | 240
Liver disease 2 | 237
Liver neoplasms 2 | 130
Metabolic syndrome X 2 | 52
Mood Disorders 2 | 184
Pick disease 2 | 1,894
Reperfusion Injury 2 | 86
Sitosterolemia 2 | 9
Type 2 diabetes mellitus 2 | 272
Xanthomatosis 2 | 12
active Crohn's disease 2 | 922
acute quadriplegic myopathy 2 | 1,158
breast carcinoma 2 | 1,638
cystic fibrosis 2 | 1,696
dermatomyositis 2 | 966
ependymoma 2 | 4,679
group 3 medulloblastoma 2 | 4,104
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
juvenile dermatomyositis 2 | 1,187
lung adenocarcinoma 2 | 2,716
lung carcinoma 2 | 2,843
pancreatic cancer 2 | 2,398
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
primitive neuroectodermal tumor 2 | 3,035
Abnormality of the musculature 1 | 16
Acanthosis Nigricans 1 | 27
Acute Lung Injury 1 | 22
Barrett Esophagus 1 | 16
Congenital anomaly of neck 1 | 19
Decreased pain sensation 1 | 17
Deformity of neck 1 | 19
Ectropion 1 | 38
Glomerulonephritis 1 | 46
Hemiplegia and hemiparesis 1 | 38
Hepatosplenomegaly 1 | 22
Ischemia 1 | 28
Lipidoses 1 | 19
Lipodystrophy 1 | 40
Lipoidosis 1 | 19
Lymphoma, T-Cell 1 | 13
Malformation of the neck 1 | 19
Myocardial Reperfusion Injury 1 | 37
Neoplasms 1 | 63
Primary Prevention of Coronary Heart Disease 1 | 4
Pulmonary alveolar proteinosis 1 | 15
Skeletal muscle hypertrophy 1 | 16
Steatohepatitis 1 | 44
T-Cell Lymphoma 1 | 13
Tangier disease 1 | 10

Tissue

Blood and immune system 6 | 16,909
Cardiovascular System 6 | 15,192
Digestive Tract 6 | 17,369
Endocrine System 6 | 18,159
Female tissues 6 | 17,400
Liver and Pancreas 6 | 16,750
Male tissues 6 | 17,142
Nervous System 6 | 16,725
Respiratory system 6 | 16,393
Skin and soft tissues 6 | 17,230
Urinary Tract 6 | 16,678

Target Family

Nuclear Receptor 4 | 48
Transporter 2 | 473

GO Process

negative regulation of cholest... 6 | 6
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
ATP-binding cassette sub-family G member 1 ABCG1 Tbio Transporter -2.52701 319.9 260
Peroxisome proliferator-activated receptor gamma PPARG Tclin Nuclear Receptor -3.96393 9579.5 773
Peroxisome proliferator-activated receptor alpha PPARA Tclin Nuclear Receptor -3.37176 2457.9 501
ATP-binding cassette sub-family A member 1 ABCA1 Tclin Transporter -3.15111 1451.8 388
Oxysterols receptor LXR-beta NR1H2 Tchem Nuclear Receptor -1.76175 49.8 287
Oxysterols receptor LXR-alpha NR1H3 Tchem Nuclear Receptor -2.19201 123.0 390